Not just coffee - even pembrolizumab works better before 11 AM ☕💉 📊 Eur J Cancer 2025 | 9-center retrospective | n=450 1L Pembrolizumab monotherapy in advanced NSCLC Timing groups: 🌅 Early ≤11:00 AM 🌙 Late >11:00 AM Results (PSM, n=206 | median f/u 62.5 mo): •OS: 43.7

Incredibly excited to join @WCMUrology and the great people working there. A massive thank you to all my mentors who helped me on the journey @HyungLKim @AjhungMD @SFreedlandMD @TimDaskivich @MichaelAhdootMD

MLAX | CHAMPIONS ONCE AGAIN!! Hard work pays off!! Your Jumbos are the 2025 NCAA Division III Men's Lacrosse National Champions!!! Back-to-back Champs!! Most Goals in NCAA Division III Championship History!!! 25-8 final!! #GoJumbos // #JumboPride // #d3lax

🎙️Very thankful to welcome @endourologyucsd as our annual Kutzmann Visiting Professor. 💡Great insights on stone management & pursuing a passion-filled career @UCSD_Urology @DeptSurgeryCS @CedarsSinaiMed @TimDaskivich @HyungLKim @Adam_Weiner535

🚨When would patients w/ #prostatecancer prefer conservative management over active treatment?🚨 @UrolOncol 👉PGY4 @john_r_heard & associate prof @TimDaskivich surveyed over 2k participants 🔑Preference for treatment changes w/ age & NCCN risk group 🔗 https://t.co/DWI9n4hYUP

🚨Surgical performance predicts erectile function after robotic🤖 prostatectomy🚨 📜 @JAMASurgery 👏PGY4 @john_r_heard & Associate Prof @AjhungMD 🔪Technical skills based on recordings from surgery can predict patient outcomes 🔗 https://t.co/PKzTRq0bFC @urotoday

🥳Congrats to the @CS_Urology residents #⃣1⃣🥇Our residents had the most abstracts accepted for any program w/ <=10 residents #aua25 @AmerUrological

How do you feel about the Urology In-Service Exam? Want to see specific changes? Tell us about your experience through our survey: https://t.co/OhT7wSO1zj For a chance to win a $100 gift card enter your email at the end! @UroResidency @UroAcademic @AmerUrological @Uro_Res

Overtreatment of Prostate Cancer Among Men With Limited Longevity in the Active Surveillance Era out on JAMA internal Medicine This cohort study analyzed #ProstateCancer treatment patterns in the Veterans Affairs health system from 2000 to 2019, focusing on men with limited life

Strong showing by our @CedarsSinai Urology residents at WS AUA in Kauai, Hi I couldn’t be more proud to be faculty to these exceptional folks @UroResidentsCS

SYSTEMATIC REVIEW 👉Noninvasive Tests for Bladder Cancer Detection and Surveillance: A Systematic Review of Commercially Available Assays 👈 by @john_r_heard @APMitra @CedarsSinai @CSCancerCenter @CedarsSinaiMed https://t.co/O15oedd19d @FaltasLab @Dan_Theodorescu @slernerbcmedu1

Congratulations to @AjhungMD for giving the Bulkey-Barry-Cooper professorial lecture yesterday on 'Automation of Skills Assessment in Robotic Surgery’ at @KingsCollegeLon! Pictured is Dr. Hung with his host @prokarurol, Chair in Robotic Surgery and Urological Innovation

It's the best day of the year!! We are so excited to match @JulieSolomonUro from @WashU_Uro and @TimothyNChu from @USC_Urology! Welcome to the family - and congrats to all who matched today! @CedarsSinai @CedarsSinaiMed @AmerUrological #UroMatch2024

What makes a great urology sub-internship? Please help us improve the sub-i experience for all by completing this 5 minute survey. Link below! There is also a chance to win a $50 dollar amazon gift card. Thank you! https://t.co/gIlImUv5YB @UroResidency @Uro_Res @AmerUrological

Walking out of PGY2 with nothing but smiles ☺️ These two are ready for their Research & Peds rotations!

#NESCAC Championship for the men of @TuftsLacrosse today. Simple formula: do you job. Do you job, trust the men to your left and your right, and it will be done. Throwback to 2012 when we won our third straight (and third ever) NESCAC Championship. Roll Bo’s! 🐘

The best part of #aua2023 was meeting new people. I was fortunate to meet TWO urologists from Turkey 🇹🇷 @Selcuk__Erdem (pictured) and Dr. Ali Riza Kural. They were incredibly kind and I hope to visit them in Istanbul later this year. @Uroturk @AmerUrological

Day 3 of #AUA2023 and the energy’s still strong!

Great work by PGY2 @john_r_heard utilizing @TempusLabs data in the invasive bladder cancer session - patients with complete response to cisplatin-based chemotherapy for advanced bladder cancer were more likely to have low levels of PDL1 expression on tumor and immune cells #AUA23

Honored to named best poster in the health services research session at #AUA23. Our data highlights the importance of culturally sensitive approaches when counseling patients regarding CaP management and life expectancy. 🙏 to @TimDaskivich for great mentorship on this project.